CLGN (CollPlant Biotechnologies Ltd Ordinary Shares) Stock Analysis - AI Report

CollPlant Biotechnologies Ltd Ordinary Shares (CLGN) is a publicly traded Healthcare sector company. As of May 21, 2026, CLGN trades at $0.45 with a market cap of $6.27M and a P/E ratio of 0.00. CLGN moved +0.00% today. Year to date, CLGN is -68.75%; over the trailing twelve months it is -77.27%. Its 52-week range spans $0.27 to $5.00. Rallies surfaces CLGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on CLGN?

Rallies AI research for CLGN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

CLGN Key Metrics

Key financial metrics for CLGN
MetricValue
Price$0.45
Market Cap$6.27M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$5.00
52-Week Low$0.27
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest CLGN News

CLGN Analyst Consensus

CLGN analyst coverage data. Average price target: $0.00.

Common questions about CLGN

What is the AI research view on CLGN?
Rallies AI research for CLGN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for CLGN?
Rallies AI research for CLGN combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is CLGN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLGN. It does not provide personalized investment advice.
CLGN

CLGN